Highlights
Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
Article first published online: 15 OCT 2008
DOI: 10.1002/eji.200838761
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Schmitz, F., Heit, A., Dreher, S., Eisenächer, K., Mages, J., Haas, T., Krug, A., Janssen, K.-P., Kirschning, C. J. and Wagner, H. (2008), Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur. J. Immunol., 38: 2981–2992. doi: 10.1002/eji.200838761
Publication History
- Issue published online: 7 NOV 2008
- Article first published online: 15 OCT 2008
- Manuscript Accepted: 21 AUG 2008
- Manuscript Revised: 20 AUG 2008
- Manuscript Received: 28 JUL 2008
Funded by
- Deutsche Forschungsgemeinschaft. Grant Number: TR22/45
Keywords:
- Caspase-1;
- IRF;
- mTOR;
- TLR
Abstract
The mammalian target of rapamycin (mTOR) can be viewed as cellular master complex scoring cellular vitality and stress. Whether mTOR controls also innate immune-defenses is currently unknown. Here we demonstrate that TLR activate mTOR via phosphoinositide 3-kinase/Akt. mTOR physically associates with the MyD88 scaffold protein to allow activation of interferon regulatory factor-5 and interferon regulatory factor-7, known as master transcription factors for pro-inflammatory cytokine- and type I IFN-genes. Unexpectedly, inactivation of mTOR did not prevent but increased lethality of endotoxin-mediated shock, which correlated with increased levels of IL-1β. Mechanistically, mTOR suppresses caspase-1 activation, thus inhibits release of bioactive IL-1β. We have identified mTOR as indispensable component of PRR signal pathways, which orchestrates the defense program of innate immune cells.

1521-4141/asset/2040_left.gif?v=1&s=92837c2f17424f89abf3f45e2642c107d62e6c04)
1521-4141/asset/EJI_right.gif?v=1&s=bce6d64154702bbe279104b1163baee31019fb77)
